Charles River Laboratories International Inc. closed 46.74% short of its 52-week high of $264.71, which the company reached ...

This was the stock's second consecutive day of losses.

Shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) have earned an average rating of ...

Corebridge Financial Inc. lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.5% during the fourth quarter, according to its most recent disclosure ...

Learn more about whether Charles River Laboratories International, Inc. or Stevanato Group S.p.A. is a better investment ...

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...

Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts ...

Avantax Advisory Services Inc. holds $315,000 in Charles River Laboratories International, Inc. (NYSE:CRL) investments.

Most readers would already be aware that Charles River Laboratories International's (NYSE:CRL) stock increased significantly by 15% over the past month. Given that stock prices are usually aligned ...

In this article, we are going to take a look at where Charles River Laboratories International, Inc. (NYSE:CRL) stands against the other best diagnostics stocks to invest in right now. According ...

Charles River and Valo Health identify a potential therapeutic for lupus using their combined offering, Logica.

The drug discovery pact between Charles River Laboratories, Valo Health and Flagship Pioneering is starting to bear fruit. | The drug discovery pact between Charles River Laboratories, Valo Health and ...